MVIS Licenses the Bluestar Genomic Health Care Index to Migdal

Frankfurt (10 May 2021) – Today, MV Index Solutions GmbH (MVIS®) announced the licensing of the BlueStar Genomic Health Care Index (ticker: BDNANTR) to Migdal Mutual Funds, a leading Israeli issuer of ETFs and index mutual funds for their second product on this index.

The BlueStar Genomic Health Care Index (ticker: BDNANTR) provides exposure to globally listed ‘Genomic Health Care’ companies, the companies must derive 50% of revenue or product pipeline from: health care therapies based on the targeting or modifying of genetic makeup of cells, technology platforms that enable the development of gene editing, or laboratory equipment or services used to test, code or develop gene editing.

The BlueStar Genomic Health Care Index (ticker: BDNANTR) is calculated in US Dollars as a total return net index. Detailed information about each index is available on MV Index Solutions website.